Sobi is a Swedish specialty pharmaceutical company focused on rare diseases, hematology, immunology, and specialty care. The company’s portfolio and commercial model are closely aligned with orphan and specialist-managed diseases. Highest 2026 tier: Tier II Specialty Pharma Companies 1 ranking category Overview
Read More
SK pharmteco is a global CDMO backed by SK Group, providing services across small molecule APIs, advanced intermediates, cell and gene therapy, viral vector manufacturing, and related pharmaceutical production. Its platform combines U.S., European, and Asian manufacturing assets.
Read More
SK bioscience is an established healthcare institution whose principal relevance to this ranking lies in vaccine development, manufacturing and global partnerships. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.
Read More
Sinovac Biotech is an established healthcare institution whose principal relevance to this ranking lies in commercial vaccines across viral and bacterial diseases. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.
Read More
Simbec-Orion is an established healthcare institution whose principal relevance to this ranking lies in early and full-service clinical development for biotech sponsors. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in contract Research Organizations.
Read More
Siegfried is a Swiss CDMO with strong capabilities in drug substance and drug product manufacturing, including active pharmaceutical ingredients, intermediates, oral solid dosage, sterile filling, and related development services. The company has built a strong reputation in pharmaceutical outsourcing across both chemical and finished-dose manufacturing.
Read More
Servier is an established healthcare institution whose principal relevance to this ranking lies in international oncology and specialty pharmaceutical development. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in global Pharmaceutical Companies.
Read More
Serum Institute of India is one of the most important vaccine manufacturers in the world by volume. Its institutional role is especially important in low- and middle-income countries, where large-scale affordable vaccine supply is essential to immunization programs.
Read More
Sarepta Therapeutics is one of the most important rare disease and neuromuscular gene therapy developers. The company is strongly associated with Duchenne muscular dystrophy, where it has developed RNA-based exon-skipping therapies and gene therapy approaches for severe neuromuscular disease.
Read More
Sanofi is one of the world’s leading vaccine companies and a major participant in immunology. Its vaccine business, historically associated with Sanofi Pasteur, spans influenza, pediatric vaccines, meningococcal disease, travel vaccines, and respiratory disease prevention.
Read More
Sana Biotechnology is an established healthcare institution whose principal relevance to this ranking lies in engineered cells and in-vivo cell-modification platforms. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in cell & Gene Therapy Developers.
Read More
Samsung Biologics is one of the most important biologics CDMO providers globally and a defining player in large-scale mammalian cell culture manufacturing. The company has built a highly standardized, large-capacity manufacturing platform in South Korea, serving major pharmaceutical and biotechnology clients across biologics development and commercial supply.
Read More
Rocket Pharmaceuticals is a specialist gene therapy company focused on rare diseases, including hematologic, immunologic, and cardiovascular genetic disorders. The company uses both lentiviral and AAV-based approaches, giving it modality diversity within genetic medicine.
Read More
Rhythm Pharmaceuticals is an established healthcare institution whose principal relevance to this ranking lies in rare genetic obesity therapies. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.
Read More
Revolution Medicines is an established healthcare institution whose principal relevance to this ranking lies in biotechnology firms. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.
Read More
Rentschler Biopharma is a specialist biologics CDMO focused on process development, clinical manufacturing, commercial manufacturing, analytical development, and regulatory support for biopharmaceutical products. The company has a long history in biologics manufacturing and serves sponsors across Europe, North America, and other markets.
Read More
Regenxbio is an established gene therapy company focused on adeno-associated virus vectors and genetic medicine. The company has built its platform around AAV delivery technology and has programs in rare disease, ophthalmology, neurodegenerative disease, and other inherited disorders.
Read More
Regeneron Pharmaceuticals is one of the strongest research-driven biotechnology firms globally, known for its antibody discovery capabilities, internal science culture, and successful commercial products across ophthalmology, immunology, oncology, and rare diseases.
Read More
Recordati Rare Diseases is a focused orphan drug platform within Recordati, serving patients with rare endocrine, metabolic, oncologic, and inherited disorders. The business has built a portfolio of specialty medicines for diseases requiring specialist diagnosis and long-term management.
Read More
Recipharm is a European CDMO with a broad pharmaceutical manufacturing platform spanning sterile manufacturing, oral solid dose, inhalation products, analytical services, development, and commercial supply. The company serves pharmaceutical and biotechnology sponsors across multiple dosage forms and therapeutic categories.
Read More